# Comparative toxicity of menthol- and tobacco-flavored electronic cigarette constituents inducing inflammation, epithelial barrier dysfunction, and nicotinic acetylcholine receptor modulation in the absence of nicotine

**Authors:** Vidhi Pandya, Arni Bhatnagar, Kirby J. Beck, Thivanka Muthumalage

PMC · DOI: 10.1016/j.toxrep.2026.102224 · Toxicology Reports · 2026-02-14

## TL;DR

This study shows that chemicals in menthol- and tobacco-flavored e-cigarettes can harm lung cells by causing inflammation and weakening the lung's protective barrier, even without nicotine.

## Contribution

The study reveals that non-nicotine flavoring chemicals in e-cigarettes can mimic nicotine's effects by altering lung cell receptors and causing inflammation.

## Key findings

- Menthol- and tobacco-flavored e-liquid chemicals disrupt epithelial barrier integrity.
- Flavor constituents alone induce IL-6 and IL-8 inflammatory cytokine responses.
- Non-nicotine flavorants increase CHRNA5 and CHRNA7 abundance, typically nicotine-driven.

## Abstract

Menthol and tobacco-flavored nicotine delivery systems (ENDS) are widely used as safer alternatives to combustible cigarettes. These flavored products include constituents such as propylene glycol/vegetable glycerin (PG/VG), benzoic acid, acetoin, l-menthone, 98 % menthone, 2-isopropyl-N,2,3-trimethylbutanamide (WS-23), vanillin, and carvone. However, little is known about the potential adverse effects of the constituents in these flavored products.

We hypothesized that exposure to common constituents of tobacco- and menthol-flavored ENDS could elicit a lung-injurious response mediated by modulation of nicotinic acetylcholine receptors (α-nAChRs or CHRNA).

Human bronchial epithelial cells, BEAS-2B, were treated with commonly used menthol and tobacco constituents on transwell inserts. Transepithelial barrier resistance (TEER) and millivolts (mV) across epithelial cells were measured over 24 h. To assess the elicited inflammatory response, cytokines IL-8 and IL-6 were quantified in the conditioned media. Cytotoxicity caused by these constituents was evaluated by acridine orange/propidium iodide (AO/PI) staining of the cells after 24 h. Alpha nicotinic receptor protein abundance (α1, α4, α5, and α7) was quantified by immunoblotting.

Epithelial integrity decreased over time, with significant decreases in TEER and voltage by ENDS constituents. A significant increase in IL-6 in conditioned media was observed in PG/VG, carvone, and WS-23 treated cells. Carvone-treated cells also elicited significantly elevated IL-8 in conditioned media. Further, increased α1, α4, α5, and α7 nAChR were seen in cells treated with PG/VG, acetoin, carvone, and WS-23.

These findings suggested that common constituents in menthol- and tobacco-flavored ENDS induce lung inflammation, epithelial barrier dysfunction, and lung injury. Further, our data implicate potential lung disease pathogenesis via α-nAChRs modulation-mediated inflammation by exposure to these ENDS constituents, even in the absence of nicotine.

•Menthol- and tobacco-flavored e-liquid chemicals disrupt epithelial barrier integrity.•Flavor constituents alone induce IL-6 and IL-8 inflammatory cytokine responses.•Non-nicotine flavorants increase CHRNA5 and CHRNA7 abundance, typically nicotine-driven.•This suggests oxidative or inflammatory upregulation independent of receptor agonism.•Nicotine-free flavor chemicals mimic nicotine-like receptor and inflammatory effects.

Menthol- and tobacco-flavored e-liquid chemicals disrupt epithelial barrier integrity.

Flavor constituents alone induce IL-6 and IL-8 inflammatory cytokine responses.

Non-nicotine flavorants increase CHRNA5 and CHRNA7 abundance, typically nicotine-driven.

This suggests oxidative or inflammatory upregulation independent of receptor agonism.

Nicotine-free flavor chemicals mimic nicotine-like receptor and inflammatory effects.

## Linked entities

- **Genes:** CHRNA5 (cholinergic receptor nicotinic alpha 5 subunit) [NCBI Gene 1138], CHRNA7 (cholinergic receptor nicotinic alpha 7 subunit) [NCBI Gene 1139]
- **Proteins:** ATP6V0A1 (ATPase H+ transporting V0 subunit a1), PLP2 (proteolipid protein 2), IGKV2D-26 (immunoglobulin kappa variable 2D-26), IGKV2D-24 (immunoglobulin kappa variable 2D-24 (non-functional))
- **Chemicals:** propylene glycol (PubChem CID 1030), benzoic acid (PubChem CID 243), acetoin (PubChem CID 179), l-menthone (PubChem CID 26447), 2-isopropyl-N,2,3-trimethylbutanamide (PubChem CID 65300), WS-23 (PubChem CID 65300), vanillin (PubChem CID 1183), carvone (PubChem CID 7439)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Diseases:** Cytotoxicity (MESH:D064420), lung injury (MESH:D055370), lung disease (MESH:D008171), lung inflammation (MESH:D011014), inflammation (MESH:D007249)
- **Chemicals:** nicotine (MESH:D009538), propidium iodide (MESH:D011419), acridine orange (MESH:D000165), 2-isopropyl-N,2,3-trimethylbutanamide (-), propylene glycol (MESH:D019946), menthone (MESH:C019466), Menthol (MESH:D008610), acetoin (MESH:D000093), benzoic acid (MESH:D019817), vanillin (MESH:C100058), Carvone (MESH:C006923), PI (MESH:D010716)
- **Species:** Homo sapiens (human, species) [taxon 9606], Nicotiana tabacum (American tobacco, species) [taxon 4097]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12989985/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12989985/full.md

## References

53 references — full list in the complete paper: https://tomesphere.com/paper/PMC12989985/full.md

---
Source: https://tomesphere.com/paper/PMC12989985